Guidelines for the diagnosis and management of heparin-induced thrombocytopenia (HIT) vary between hospitals. Recent guidelines recommend initiating alternative anticoagulant therapy in patients with suspected HIT while awaiting laboratory test results confirming the presence of heparin-PF-4 antibodies (PF-4). This retrospective chart review was designed to assess the current state of management of patients with thrombocytopenia suspected to be due to HIT at 26 US hospitals. Most hospitals (25 of 26; 96.2%) had guidelines in place for the management of suspected HIT, with 7 (26.9%) having a "halt heparin, test, and await results" (ie, "test and wait") policy. One-third of hospitals had a wait time for obtaining PF-4 antibodies of 3 days or more. Hospital guidelines for the management of HIT may actually discourage the use of optimal HIT management strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1076029612456732 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Early warning systems for identifying severe maternal outcomes: findings from the WHO global maternal sepsis study.
EClinicalMedicine
January 2025
Malawi-Liverpool Wellcome Programme, Blantyre, Malawi.
Background: Infections and sepsis are leading causes of morbidity and mortality in women during pregnancy and the post-pregnancy period. Using data from the 2017 WHO Global Maternal Sepsis Study, we explored the use of early warning systems (EWS) in women at risk of sepsis-related severe maternal outcomes.
Methods: On April 27, 2023, we searched the literature for EWS in clinical use or research in obstetric populations.
Imaging flow cytometry as a novel approach for the diagnosis of heparin-induced thrombocytopenia.
Br J Haematol
December 2024
Service d'Hématologie Biologique, CHU Amiens-Picardie, Amiens, France.
Heparin-induced thrombocytopenia (HIT) is an adverse reaction characterized by anti-PF4-heparin antibody generation and hypercoagulability. Imaging flow cytometry (IFC) provides a detailed morphological analysis of platelets, which change upon activation. We evaluated IFC-derived morphometric features to detect platelet activation and developed a functional assay for HIT diagnosis.
View Article and Find Full Text PDFPractical guide to the diagnosis and management of heparin-induced thrombocytopenia.
Hematology Am Soc Hematol Educ Program
December 2024
Department of Medicine and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Heparin-induced thrombocytopenia (HIT) is an immune reaction to heparin associated with thrombocytopenia, thrombotic risk, and a high risk of morbidity and mortality. Given the frequent use of heparin and the common occurrence of thrombocytopenia in hospitalized patients, the diagnosis and management of HIT is a recurrent challenge in everyday inpatient care. This article presents practical guidance and tools to support the individual clinician providing evidence-based care to patients with suspected or confirmed HIT.
View Article and Find Full Text PDFProspective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors.
Cancers (Basel)
November 2024
Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
Background: The etiology of most mesenchymal tumors is unknown, and knowledge about syndromes with an increased risk of tumors in bone or soft tissue is sparse.
Methods: We present a prospective germline analysis of 312 patients with tumors suspected of being sarcomas at a tertiary sarcoma center. Germline and tumor whole genome sequencing, tumor transcriptome, and methylome analyses were performed.
Heparin-induced thrombocytopenia-II in hospitalized patients with surgery or deep vein thrombosis.
Am J Blood Res
October 2024
Nerophysiology Research Center, Hamadan University of Medical Sciences Hamadan, Iran.
Article Synopsis
- This study examines heparin-induced thrombocytopenia (HIT-II), a serious complication in hospitalized patients receiving heparin, particularly after surgery or for deep vein thrombosis (DVT).
- The research involved 754 patients and found a HIT-II incidence rate of 4.50%, with higher occurrences in older adults and females, along with increased thrombosis rates and elevated levels of various inflammatory markers.
- The study concludes that platelet activation in HIT-II patients contributes to more thrombosis formation, longer hospital stays, and higher mortality rates compared to non-HIT patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!